Audax Private Equity today announced that it has completed the sale of WellSpring Consumer Healthcare to Avista Capital Partners.
Established in 1999 and headquartered in Sarasota, Florida, WellSpring is a leading marketer of iconic over-the-counter brands primarily in the skin care and gastrointestinal care categories. WellSpring’s product portfolio includes long-standing brands such as Bactine, Bonine, Emetrol, Glaxal Base, FDS, Micatin, Gelusil, Barriere, and K-Lyte. The Company sells to retailers and consumers through a network of distribution partners and direct salespeople.
Since being acquired by Audax in 2017, WellSpring has undergone a period of transformation, growth, and success, including:
- Expanding the company’s product offerings in high-growth categories with unmet consumer needs
- Bolstering R&D capabilities in-house and broadening network of innovation partners
- Driving significant growth across retail and e-commerce channels with industry-leading sales and marketing efforts
Read more: Business Wire
